Yorkshire Concept Board Meeting, December 2009
The latest approved projects are:
Rescudent
A team at the University of Leeds have identified an attractive commercial opportunity for provision of training and equipment to medical professionals. We will launch the product in mid 2010. The details of the product will be kept confidential until product launch to avoid competitors copying our idea and to give us first mover advantage
Behaviour 2 Neurochemistry (B2N)
Behaviour to Neurochemistry is a preclinical testing service assessing the efficacy of new therapies to improve cognitive dysfunction in schizophrenia and other disorders. It is currently run as an academic enterprise. Yorkshire Concept Funding will provide the management, sales and marketing resources required to turn it into a commercial entity
Power Efficient Laser Cavity Media
Research breakthroughs in specialist glass at the University of Leeds have enabled the development of next generation eye-safe laser technology. Products resulting from the project will allow the production of lasers which use less power, are more reliable, lighter weight, more robust, and lower cost. This will particularly benefit applications in the military area.
Commercial Development of a Novel Anticoagulant with Minimal Bleeding Risk
Researchers at the University of Leeds are developing a new oral drug (anticoagulant) against the development of blood clots. This presents for the first time the potential for an anticoagulant with minimal bleeding side effects. Yorkshire Concept funding will enable the development of the commercial strategy for taking the drug to market
RadiVis: A new safety technology
RadiVis is a technology to be incorporated in garments in order to render the wearer distinctively visible to radar. It offers a unique and improved detection capability with the potential for saving lives and has already attracted key segments of the Search and Rescue market.
Imaging Electromagnetic Flowmetering
Engineers at the University of Huddersfield have developed a new imaging technique that can significantly improve the accuracy of flow measurement in multiphase and difficult single phase flow conditions. The Yorkshire Proof of Commercial Concept Fund is being used to develop a commercial flowmeter product based on this new technology.
